Introduction
Monosodium glutamate (MSG) is a food additive that acts as a preservative or as an enhancer of palatability and is locally called in Nigeria Ajinomoto. MSG is the sodium salt of non-essential amino acids in human foods. When present in free form, it has a flavor enhancing effect and for this reason it is added to foods as purified monosodium salt. In early 1900s scientists isolated the ingredient (glutamate) in plants that is the essential taste component responsible for the greatly enhancing flavor (1) . Glutamate occurs naturally in virtually all foods, including meat, fish, poultry, breast milk and vegetables, with vegetables tending to contain proportionally higher levels of free glutamate (as MSG). Various processed and prepared foods such as traditional seasoning sauce and certain restaurant foods contain significant levels of free glutamate (as MSG), both from natural sources and from added monosodium glutamate (13, 28) . In the early part of the twentieth century, MSG was extracted from seaweed and other plant sources, today it is produced in many countries around the world through a natural fermentation process using molasses from sugar cane or sugar beets, as well as starch and corn sugar (17) . However, in large quantities or amounts, it may cause chest pain, sensation of facial pressure, headaches, burning sensation, excessive fluid retention and sweating. Studies have shown that the body uses glutamate as a nerve impulse transmitter and that there are glutamate-responsive tissues all over the body and also used intravenously as an adjunct in the treatment of encephalopathy associated with hepatic disease (31) . However, the safety of MSG usage has generated such controversial argument locally and internationally, (5) . MSG has a toxic effect on the testes by causing a significant oligozoospermia and increased abnormal sperm morphology in a dose-dependent fashion in male wistar rats (26) . It has been implicated in male infertility by causing testicular hemorrhage, degeneration and alteration of sperm cell population and morphology (25) . Studies have also shown that Glutamate (MSG) causes reduction in the secretion of growth hormones, leading to stunted growth and irreversibility in obesity, excessive weight, essentially due to the accumulation of excess fats in adipose tissue (13, 21, 28 ) , arising from high cholesterol levels leading to cardiovascular diseases and endocrinological disorder (13) . The aim of this study was to investigate the effects of Monosodium Glutamate on platelet count, thrombocyte, coagulation and bleeding time in rats.
II. Materials And Methods

Experimental Animals
Sixteen adult male wistar rats weighing between 140 and 200g were used for this study. The rats were obtained from the animal house, Bingham University, Karu, Nasarawa State, Nigeria and were acclimatized for a period of two weeks before the commencement of the study. They were randomly grouped and kept in clean cages in a temperature-controlled romm with 12-hr light/dark schedule. They had access to rats chow and water was supplied ad-libitum.
Acute Toxicity Test
Acute toxicity study: Lethal dose (LD 50 ) of monosodium glutamate was determined by the method of Lorke,(1), using 16 rats. In the first phase, rats were divided into four groups, containing two rats each and were treated with monosodium glutamate at doses of 2.5g/ml bw, 3.5g/ml bw, 4.0g/ml bw and 4.5g/ml bw were given by oral gavage. They were observed for twenty four hours for toxicity signs. In the second Phase, rats were divided into four groups, each group had two rats. They were treated at doses of 5.5g/ml bw, 10.5g/ml, 15.5g/ml and 16.5g/ml bw by oral gavage. The acute toxicity LD50 was calculated as the geometric mean of the dose that resulted in 100% mortality and that which caused no lethality at all.
Preparation of Monosodium Glutamate
Monosodium glutamate (MSG) was obtained from Mararaba market, Abuja, Nigeria for use in this study. A stock solution was prepared by dissolving MSG granules in 695 ml of distilled water, from this and based on the animal weight, 340.48g dosage was administered orally to the animals in the test groups 2, 3, and 4. Group one served as the control group; group two received 13.28g/ml bw of MSG; group three received 6.64g/ml bw of MSG; while group four had 4.40g/ml bw of MSG for 14 days respectively.
Blood Collection
At the end of monosodium glutamate treatment, the rats were anesthetized with diethyl ether and blood samples were collected via cardiac puncture into EDTA bottles for hematological indices.
Blood Thrombocytes count
The Rees Ecker's method was applied for blood thrombocyte count. The number of platelets was calculated per µL (x 10 9 L)0f blood. The average number of platelets counted on both sides of the counting chamber was multiplied by 1000 to get the total platelet count/mm 3 (6) .
Blood Coagulation
The rats tails were warmed for one minute at 40 0 C, the tails were dried and cut at the tip with a sterile razor. The blood samples collected were kept in silicon glass test tubes. The glass test tubes were labeled 1, 2 and 3 respectively. About 1 to 2ml of blood were placed in each of the three glass test tubes. However, the stop watch was started as soon as blood enters the tubes. All tubes were placed in 37 0 C water bath and the tube labeled three was tilted gently at an angle of 45 for every 30 seconds until the blood clots. Also, tube labeled two was done in like manner until the blood was allowed to clot. Tube labeled one was tilted until no blood flow was observed on tilting. The time taken was recorded. The coagulation time was the time required for blood to clot in the last tube (tube labeled one), (34) .
Bleeding
The rats tails were sterilized and were warmed for 1 minutes in water bath at 400C and then dried. This was measured by cutting the tail-tip (33) with a sterile lancet. A stop watch was started immediately. Blood was blotted every 30 seconds using Whitman filter paper until bleeding ceased. The time taken for the blood to stop flowing was recorded as the bleeding time, (22) .
Statistical analysis
The data were expressed as mean ± SEM. Readings within a group were compared using the one-way ANOVA analysis and readings between groups were compared using the Independent sample test. Statistical analysis was performed using SPSS (Version 17). A level of p <0.05 was considered to be significant. The results in table 1 showed that monosodium glutamate was toxic at a concentration of 16.5g/ml in which there was a percentage mortality of 100 (%). However, no mortality was observed in groups treated with 5.5, 10.5, and 15.5g/ml bw of monosodium glutamate given orally after a period of 24 hours. Hence, the LD 50 was taken to be 16.5g/ml. The results in table two showed that there was a significant increase (p<0.05) in mean body weight of groups 3 treated with 6.64g/ml monosodium glutamate when compared with the control group. However, there was significant difference (p<0.05) in platelet values of groups 2 and 3. There was a significant increase (p<0.05) in bleeding time value of group 2 treated rats when compared with the control. There was an insignificant difference (p>0.05) in bleeding time of group 3 treated rats when compared with the control group. However, there was a significant decrease (p<0.05) in bleeding time of group 4 treated rats when compared with the control group. There was a significant increase (p<0.05) in the mean clotting time of group 2 treated rats when compared with their control counterpart. However, there was an insignificant difference (p>0.05) in group 3 treated rats when compared with the control group. There was a significant decrease (p<0.05) in group 4 treated rats when compared with the control counterpart.
III. Results
IV. Discussion
Hemostasis has been divided into vascular/platelet phase and coagulation phase, the tests available for the first phase are bleeding time, platelet count and platelet function assay (11) . However, the tests available to test the coagulation phase of hemostasis are whole blood clotting time, prothrombin time, activated plasma thromboplastin time, thrombin time. The bleeding time is affected by large number of diseases, drugs, physiologic factors, test conditions, and therapeutic actions, not all of the above mentioned are platelet related (12) . However, the results in this study showed that Monosodiun glutamate (MSG) significantly increased the platelet cell counts of rats treated with high concentration of 13.28g/ml MSG for 14 days consecutively. There was also a significant increase in the platelet cell count of rats treated with 6.64g/ml MSG for 14 days as shown in table 4 above. This indicates that high concentration of MSG treatment may seems to lead to an increased number of platelet cell in the blood known as thrombocytosis or thrombocythemia. It was also suggested that the increase might be due to the excessive intake of one of MSG component which includes sodium and glutamate that affect blood and body fluid compartments and water balance of the body. However, the mechanism of action of Monosodium glutamate by altering the platelet cells, in the body is yet to be fully elucidated. The hormone, called Thrombopoietin, stimulates the production of platelets, which promote blood clotting. Its discovery is expected to benefit cancer or lymphoma patients who have received chemotherapy or a bone marrow transplant. These patients have low platelet counts, putting them at serious risk of death from bleeding. Currently they are treated with transfusion of platelets, which requires time-consuming procedures and many
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www.iosrjournals.orgblood donors. Thrombopoietin seems able to increase platelets to previously unattainable levels. Thrombopoietin secreted by the kidneys and produces platelet cells. However, with renal failure there is a decrease in production of this hormone and thrombocytopenia results. The results in this study suggest that administration of MSG for 14 days at a dose of 4.40g/ml did not cause an increase in platelet cell count but caused a decrease in platelet count and this may be dose dependent. Also, the result in this study shows that bleeding and clotting time were increased following administration of Monosodium glutamate at doses of 13.28g/ml and 6.64g/ml for 14 days which may be as a result of water retension in the fluid compartments of rats treated with high dose of MSG. In conclusion, it was observed from this study that Monosodium glutamate has a significant effects on the platelet count which may be indicative of thrombocythemic conditions in the treated rats. Hence, these findings support the fact that Monosodium glutamate taken in excess despite its flavouring functions is detrimental to health (14) .
